期刊文献+

克拉霉素胶囊人体相对生物利用度实验研究 被引量:2

Bioavailability of clarithromycin capsule in normal volunteers
暂未订购
导出
摘要 12名健康志愿者随机自身交叉口服单剂量500mg国产克拉霉素胶囊或进口片剂进行生物利用度研究,用微生物杯碟法测定血清中克拉霉素浓度。结果表明克拉霉素胶囊和片剂两种制剂的体内药时数据符合二室模型,Cmax分别为2.44和2.78μg/ml;tp为2.29和2.07h;为6.81和7.39h;AUC为23.68和24.05mg·h·L-1。克拉霉素胶囊相对生物利用度为99.86±19.28%,表明国产克拉霉素胶囊与进口片剂具有生物等效性。 he bioavailability of clarithromycin capsule was studied in 12 normal male volunteers. A single oral dose of 500mg clarithromycin capsule or tablet was given according to a crossover design. Serum concentrations of clarithromycin were measured by bioassay. The concentration - time curves of both capsule and tablet fitted to a two - compartment open model. Peak serum levels of capsule and tablet reached 2.44 and 2.78μg/ml, at 2.29 and 2. 07h. respectively. The were 6.80 and 7.39h. The AUC were 23.68 and 24.05mg . h . L . ,respectively. The relative bioavailability of capsule to tablet was 99.8±19.28%, and it demonstrated that both formation had bioequivalence.
出处 《重庆医科大学学报》 CAS CSCD 1999年第2期161-163,共3页 Journal of Chongqing Medical University
关键词 克拉霉素 相对生物利用度 胶囊 国产 Clarithromycin Pharmacokinetics Bioavailability
  • 相关文献

参考文献3

二级参考文献3

共引文献2

同被引文献12

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部